-
Posted: April 12th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: MDR modulator CBT-1; Drug: paclitaxel; Drug: technetium 99m sestamibi; Procedure: chemosensitization/potentiation therapy; Procedure: drug resistance inhibition treatment; Procedure: parenteral chemotherapy; Procedure: radionuclide imaging
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2008
-
Posted: March 14th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: indinavir sulfate; Drug: ritonavir; Procedure: antiangiogenesis therapy; Procedure: drug modulation therapy; Procedure: enzyme inhibitor therapy; Procedure: radiation therapy; Procedure: radiosensitization
Sponsor: Oncology Institute of Southern Switzerland - Lugano
Recruiting - verified March 2008
-
Posted: February 22nd, 2008, 10:00am EST
Conditions: Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Pancreatic Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib; Drug: cetuximab; Procedure: enzyme inhibitor therapy; Procedure: monoclonal antibody therapy
Sponsors: Masonic Cancer Center at University of Minnesota; National Cancer Institute (NCI)
Active, not recruiting - verified March 2008
-
Posted: February 20th, 2008, 10:00am EST
Conditions: Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Sarcoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride; Procedure: antiangiogenesis therapy; Procedure: chemotherapy; Procedure: enzyme inhibitor therapy; Procedure: pharmacological study
Sponsors: Masonic Cancer Center at University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified March 2008